H5N1 News and Research

Latest H5N1 News and Research

New strain of bird flu poses pandemic threat

The World Health Organization (WHO) is calling the new strain of H7H9 influenza virus "lethal" and The University of Kansas Hospital is preparing now for any potential cases.

26 Apr 2013

H7N9 flu virus found to transmit from birds to humans but not person-to-person

Scientists in China have confirmed for the first time that the influenza A H7N9 virus has transmitted from birds—specifically, chicken at a wet poultry market—to humans, according to an Article published Online First in The Lancet.

25 Apr 2013

Chinese bird flu continues to spread

The H7N9 avian influenza outbreak in China is continuing to spread, although authorities believe that the large majority of those affected did not become infected via human-to-human contact.

25 Apr 2013

To avoid difficulties experienced during SARS epidemic, China must remain transparent in H7N9 efforts

"On this 10th anniversary of China's April 2003 admission that the SARS virus had spread across that country ... Beijing finds itself once again in a terrible position via-a-vis the microbial and geopolitical worlds," Laurie Garrett, a senior fellow for global health at the Council on Foreign Relations, writes in a Foreign Policy opinion piece, noting the emergence of a new strain of bird flu, H7N9, in the country.

25 Apr 2013

SynCon universal H1N1 influenza vaccine generates protective antibody levels in phase 1 study

Inovio Pharmaceuticals, Inc. announced today that its SynCon universal H1N1 influenza vaccine generated protective antibody levels comparable to a current FDA-approved seasonal influenza vaccine against a currently circulating influenza strain.

19 Apr 2013

Clinical data of EV71 vaccine for prevention of HFMD presented at World Vaccine Congress & Expo

Sinovac Biotech Ltd., a leading provider of vaccines in China, announced today that Fengcai Zhu, Deputy Director of the Jiangsu Provincial Center for Disease Prevention and Control, presented data regarding Sinovac's proprietary enterovirus 71 ("EV71") vaccine against hand, foot and mouth disease at the 13th Annual World Vaccine Congress & Expo, taking place from April 16-18, 2013, in Washington D.C.

19 Apr 2013

New assays are effective in managing patients with influenza virus infection

Over 40,000 people die each year in the United States from influenza-related diseases. In patients whose immune systems are compromised, antiviral therapy may be life-saving, but it needs to be initiated quickly. It is therefore crucial to diagnose and type the influenza rapidly.

18 Apr 2013

IDRI, Medicago announce positive Phase I clinical trial results for avian flu pandemic vaccine

IDRI, a Seattle-based non-profit research organization that is a leading developer of adjuvants used in vaccines combating infectious disease, and Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today reported positive interim results from a Phase I clinical trial for an H5N1 Avian Influenza VLP vaccine candidate.

18 Apr 2013

Medicago, IDRI to present Phase I clinical results of H5N1 vaccine at World Vaccine Congress

IDRI, a Seattle-based non-profit research organization that is a leading developer of adjuvants used in vaccines combating infectious disease, and Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today announced that they will be presenting positive interim Phase I clinical results for their H5N1 Avian Influenza VLP vaccine candidate "H5N1 vaccine" at the World Vaccine Congress.

9 Apr 2013

Research findings could help develop effective vaccines against new strains of bird flu

Scientists have described small genetic changes that enable the H5N1 bird flu virus to replicate more easily in the noses of mammals.

9 Apr 2013

WHO considers sending experts to China as death toll from H7N9 virus hits 7

The WHO "is talking with the Chinese government about sending international experts to China to help investigate a new bird flu strain that has sickened at least 24 people, killing seven of them," the Associated Press reports.

9 Apr 2013

A*STAR's professor receives Szent-Gy-rgyi prize for groundbreaking cancer pill

Professor Alex Matter, Chief Executive Officer of A*STAR's Experimental Therapeutics Centre (ETC), has been awarded the 8th Annual Szent-Gy-rgyi Prize for Progress in Cancer Research by the National Foundation for Cancer Research (NFCR) for his contributions to the development of the first drug specifically targeting a molecular lesion in cancer.

7 Apr 2013

China reports 4 more cases of H7N9 bird flu virus; Officials investigating route of transmission

"On Tuesday, China reported four more cases of infection with the H7N9 influenza virus, a type of bird flu, in the eastern Jiangsu province," Time reports.

4 Apr 2013

New strain of avian flu kills two Chinese men, officials say

"Two people in China have died and another remains critical after falling ill with a strain of bird flu not detected before in humans, the official Chinese news agency Xinhua reported," CNN reports (Mullen, 4/1).

2 Apr 2013

New vaccine proves highly effective against H5N1 virus

Until now most experimental vaccines against the highly lethal H5N1 avian influenza virus have lacked effectiveness. But a new vaccine has proven highly effective against the virus when tested in both mice and ferrets. It is also effective against the H9 subtype of avian influenza.

26 Mar 2013

UCLA researchers predict hotspots for future outbreaks of influenza virus

This year's unusually long and rocky flu season would be nothing compared to the pandemic that could occur if bird flu became highly contagious among humans, which is why UCLA researchers and their colleagues are creating new ways to predict where an outbreak could emerge.

17 Mar 2013

NanoViricides retires Series C Convertible Preferred Stock previously purchased by Seaside

NanoViricides, Inc., announced today that it has retired the remainder of the Series C Convertible Preferred Stock previously purchased by Seaside 88, LP, with a cash payment.

27 Feb 2013

U.S. health officials outline new policies for funding research on H5N1 avian flu, other potentially dangerous agents

"U.S. health authorities on Thursday outlined the conditions for funding research on the H5N1 bird flu virus a month after scientists lifted a yearlong pause on the work that was imposed amid concerns it could be used by terrorists," Bloomberg reports.

23 Feb 2013

Cambodia, China report cases of avian influenza H5N1

"Cambodia reported on Wednesday that another four-year-old girl has contracted avian influenza H5N1, becoming the seventh person who infected the virus in 2013," Xinhua reports.

14 Feb 2013

Global response to possible H5N1 flu outbreak could affect epidemic's course

"It's been a rough flu season this winter in the United States and Europe, but it could be worse. A lot worse," science writer Carl Zimmer states in National Geographic's "Phenomena: The Loom" blog.

10 Feb 2013

H5N1 News and Research

Latest H5N1 News and Research

New strain of bird flu poses pandemic threat

H7N9 flu virus found to transmit from birds to humans but not person-to-person

Chinese bird flu continues to spread

To avoid difficulties experienced during SARS epidemic, China must remain transparent in H7N9 efforts

SynCon universal H1N1 influenza vaccine generates protective antibody levels in phase 1 study

Clinical data of EV71 vaccine for prevention of HFMD presented at World Vaccine Congress & Expo

New assays are effective in managing patients with influenza virus infection

IDRI, Medicago announce positive Phase I clinical trial results for avian flu pandemic vaccine

Medicago, IDRI to present Phase I clinical results of H5N1 vaccine at World Vaccine Congress

Research findings could help develop effective vaccines against new strains of bird flu

WHO considers sending experts to China as death toll from H7N9 virus hits 7

A*STAR's professor receives Szent-Gy-rgyi prize for groundbreaking cancer pill

China reports 4 more cases of H7N9 bird flu virus; Officials investigating route of transmission

New strain of avian flu kills two Chinese men, officials say

New vaccine proves highly effective against H5N1 virus

UCLA researchers predict hotspots for future outbreaks of influenza virus

NanoViricides retires Series C Convertible Preferred Stock previously purchased by Seaside

U.S. health officials outline new policies for funding research on H5N1 avian flu, other potentially dangerous agents

Cambodia, China report cases of avian influenza H5N1

Global response to possible H5N1 flu outbreak could affect epidemic's course

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

H5N1 News and Research

Latest H5N1 News and Research

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in